The latest report by IMARC Group, titled “Oxygen Therapy Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2032,” offers a comprehensive analysis of the global oxygen therapy market. The report also includes competitor and regional analysis, along with a breakdown of segments within the industry.

The global oxygen therapy market size reached US$ 18.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 33.5 Billion by 2032, exhibiting a growth rate (CAGR) of 6.4% during 2024-2032.

Request a Sample Report: https://www.imarcgroup.com/oxygen-therapy-market/requestsample

Oxygen Therapy Market Trends:

The increasing prevalence of respiratory diseases, such as chronic obstructive pulmonary disease (COPD) and asthma, is driving the global market. Moreover, the rising geriatric population, which is more susceptible to respiratory ailments, fuels market growth. Technological advancements in oxygen therapy devices, enhancing their efficacy and patient convenience, further contribute to the market expansion. Additionally, the growing awareness of the benefits of early diagnosis and treatment of respiratory conditions encourages the adoption of oxygen therapy.

Furthermore, the rise in healthcare expenditure and improved healthcare infrastructure, especially in developing regions, enhances market growth potential. Besides, favorable government initiatives and policies aimed at improving respiratory care boost the market. The increasing adoption of home healthcare services, driven by the need for cost-effective and comfortable patient care, also accelerates market growth. The expanding application of oxygen therapy in various medical conditions beyond respiratory diseases, such as cardiovascular and neurological disorders, broadens its market scope.    

Oxygen Therapy Market Scope and Growth Analysis:

The scope of the market is expanding due to the integration of advanced technologies such as portable oxygen concentrators and smart inhalers. Furthermore, the market is expanding geographically, with increased penetration in emerging economies due to improving healthcare infrastructure and growing awareness of respiratory health. Additionally, collaborations and partnerships among key players in the industry for the development of innovative products and the expansion of their distribution networks are fostering market growth. The increasing use of oxygen therapy in palliative care and for post-surgical recovery is also contributing to its expanding scope.

Moreover, the growing investment in research and development to create more efficient and patient-friendly oxygen delivery systems is augmenting the market forward. The rising prevalence of chronic diseases and the consequent demand for long-term oxygen therapy are further propelling the market's growth. The favorable reimbursement policies in various countries are making oxygen therapy more accessible to a larger patient population, enhancing the overall market scope.    

View Full Report with TOC & List of Figure: https://www.imarcgroup.com/oxygen-therapy-market

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

• Allied Healthcare Products Inc.,
• Becton Dickinson and Company,
• DeVilbiss Healthcare LLC (Drive Medical Inc.),
• Fisher & Paykel Healthcare Limited,
• General Electric Company,
• Getinge AB,
• Hersill SL,
• Invacare Corporation,
• Koninklijke Philips N.V,
• Smiths Group plc,
• Tecno-Gaz S.p.A.,
• Teleflex Incorporated

Oxygen Therapy Market Segmentation:

Our report has categorized the market based on region, product, application, and end use.

Breakup by Product:

• Oxygen Source Equipment
  • Oxygen Cylinders
  • Oxygen Concentrators
  • Liquid Oxygen Devices
  • PAP Devices
• Oxygen Delivery Devices
  • Oxygen Masks
  • Nasal Cannula
  • Venturi Masks
  • Non-rebreather Masks
  • Bag Valve Masks
  • CPAP Masks
  • Others

Breakup by Application:

• Chronic Obstructive Pulmonary Disease
• Asthma
• Obstructive Sleep Apnea
• Respiratory Distress Syndrome
• Cystic Fibrosis
• Pneumonia
• Others

Breakup by End Use:

• Home Healthcare
• Hospitals

Breakup by Region:

• North America (United States, Canada)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Asia Pacific (China, Japan, India, Australia, Indonesia, South Korea, Others)
• Latin America (Brazil, Mexico, Argentina, Colombia, Chile, Peru, Others)
• Middle East and Africa (Turkey, Saudi Arabia, Iran, United Arab Emirates, Others)

Key Highlights of the Report:

• Market Performance (2018-2023)
• Market Outlook (2024-2032)
• Porter’s Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

About US:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic, and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800